We made it to the end of another series. In our FINAL episode of the prostate cancer series, we turn our attention to metastatic castrate-resistant prostate cancer! We discuss treatment options, the data behind why we do what we do, and more targeted agents.
Content:
- Approach to metastatic castrate-resistant prostate cancer
- Refresher on what it means to be castrate-resistant
- Role of bisphosphate therapy and denosumab
- Treatment options and data surrounding sequencing of agents
- Other options for prostate cancer (radium-223 and lutetium-177-PSMA-617)
- Role of PARP inhibitors in BRCA-mutated disease
** Want to review the show notes for this episode and others? Check out our website: https://www.thefellowoncall.com/our-episodes
Love what you hear? Tell a friend and leave a review on our podcast streaming platforms!
Twitter: @TheFellowOnCall
Instagram: @TheFellowOnCall
Listen in on: Apple Podcast, Spotify, and Google Podcast